What is more important: The benefit of taking a cholesterol-lowering statin drug to protect against heart attacks and strokes, or the increased risk of developing diabetes that might accompany the medication in some patients?
While a new study concluded that the heart-disease prevention benefits outweigh the diabetes risk, Scripps Clinic cardiologist Eric Topol, M.D., continues to warn against over prescribing the popular drugs.
“Although there is a narrow trade-off with the benefits of reducing heart disease, this paper doesn’t mitigate the (diabetes) concern to me,” the Scripps Health chief academic officer told The Wall Street Journal in a recent article about the study.
Dr. Topol also weighed in on the controversy in coverage by USA Today and The Boston Globe.
Read those full articles here: